Assessment of an Adherent HEK293 Cell Transfection Process for Scalable AAV Production in the iCELLis® 500 Fixed-Bed Bioreactors

被引：0
|
作者：
Kaspar, Brian K. [1 ]
Gardell, Brian [2 ]
Chung, Keen [2 ]
Vallabhaneni, Deepika [2 ]
Legmann, Rachel [2 ]
机构：
[1] AveXis Inc, Bannockburn, IL USA
[2] Pall Life Sci, Westborough, MA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
478
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [21] Development of a scalable viral vector upstream process for gene therapy: rAAV-8 production by transfection of HEK-293 cells in iCELLis™ bioreactor
    Reniers, R. Andy
    Van Huffel, V. Christophe
    Merten, M. Otto-Wilhelm
    Hebben, H. Matthias
    Rousseau, R. Cedrick
    Arias, A. Simon
    Hohoud, H. Moustapha
    Lievrouw, L. Roel
    Moncaubeig, M. Fabien
    Nowicki, N. Paule
    Cancian, C. Catherine
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A88 - A88
  • [22] Evaluation of the Single-Use Fixed-Bed Bioreactors in Scalable Virus Production
    Lesch, Hanna P.
    Valonen, Piia
    Karhinen, Minna
    [J]. BIOTECHNOLOGY JOURNAL, 2021, 16 (01)
  • [23] Upscaling AAV production for research purposes: development of HEK293 suspension cell-based AAV production protocol
    Pietersz, K. L.
    Klunder, M. H. M.
    Hobo, B.
    van den Herik, J.
    Nijhuis, P. J. H.
    de Winter, F.
    Verhaagen, J.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A112 - A112
  • [24] Manufacturing of AAV-hFIX particles in an iCELLis® 500 fixed-bed bioreactor meets commercial-scale requirements
    Rehberger, B.
    de Carli, C.
    Hanselka, S.
    Sonntag, F.
    Weber, R.
    Sedlmeier, S.
    Lee, M.
    Zach, C.
    Irfan, K.
    Hohoud, M.
    Hoerer, M.
    [J]. HUMAN GENE THERAPY, 2017, 28 (12) : A66 - A67
  • [25] A Robust Commercial rAAV-Vector Platform Process Using the iCELLis® 500 Fixed-Bed Bioreactor
    De Carli, Christian
    Boscher, Matthias
    Hanselka, Sarah
    Jankiewicz, Marcin
    Zach, Christine
    Sonntag, Florian
    Schulze, Andreas
    Prieler, Bettina
    Rehberger, Bernd
    Bhatia, Jeet
    Said, Najeeb
    Irfan, Kerem
    Hohoud, Mustapha
    Mainwaring, David
    Horer, Markus
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 329 - 330
  • [26] In vitro and in vivo comparability assessment of an AAV vector manufactured by triple transfection in HEK293 cells or in the baculovirus expression system
    Steel, M.
    Woodburn, K.
    Kniffin, T.
    Gebretsadik, K.
    Chan, J.
    Vijay, S.
    Chen, H.
    Chalberg, T. W.
    Gasmi, M.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A70 - A70
  • [27] Production Media Screening and Harvest Depth Filter Comparison from Different Vendors for AAV Production by Transient Transfection Mediated HEK293 Suspension Cell Culture
    Zubairy, Nida S.
    Xiang, Tao
    Zhou, Jiangshan
    Arimpur, Udhaya
    Lin, Roy
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 540 - 540
  • [28] Strategy for Derivation and Optimization of a Clonal HEK293 Suspension Cell Line for High Yield AAV Production
    Mcilhatton, Michael A.
    Ketz, John
    Bergman, Sarah
    Hurley, Brittany
    Carper, Byron
    Moreo, Andrew
    Acharya, Samir
    [J]. BIOPHARM INTERNATIONAL, 2024, 37 (05)
  • [29] Linear scalability of virus production in the integrity® iCELLis® single-use fixed-bed bioreactors from bench to industrial scale
    Shane Knowles
    Jean-Christophe Drugmand
    Nicolas Vertommen
    Jose Castillo
    [J]. BMC Proceedings, 7 (Suppl 6)
  • [30] Development and scale-up of a transient AAV production process using a suspension-adapted HEK293 clone
    Fong, E.
    Ushijima, A.
    Skubish, E.
    George, H.
    Patel, S.
    Orlando, J.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A121 - A121
12345